Study of levels of latamoxef in prostatic tissue and bladder mucosal tissue

The concentration of Latamoxef (LMOX) in the serum, prostatic tissue and bladder mucosal tissue of 20 patients with benign prostatic hypertrophy and bladder cancer was measured after intravenous infusion of 1 g or 2 g of LMOX. Serum, prostatic tissue and bladder mucosal tissue levels of LMOX respond...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 33(1987), 2 vom: 01. Feb., Seite 289-93
Auteur principal: Nakata, Y (Auteur)
Autres auteurs: Mizunaga, M, Morikawa, M, Osanai, H, Fujisawa, M, Inada, F, Yachiku, S
Format: Article
Langue:Japanese
Publié: 1987
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Journal Article Moxalactam VUF6C936Z3
Description
Résumé:The concentration of Latamoxef (LMOX) in the serum, prostatic tissue and bladder mucosal tissue of 20 patients with benign prostatic hypertrophy and bladder cancer was measured after intravenous infusion of 1 g or 2 g of LMOX. Serum, prostatic tissue and bladder mucosal tissue levels of LMOX responded satisfactorily to the dose of LMOX. The bladder mucosal tissue level was higher than the prostatic tissue levels. Judging from the inhibitory concentration of LMOX (MIC 80), the concentration was sufficiently effective against infections caused by gram-negative, gram-positive and anaerobic bacilli
Description:Date Completed 14.07.1987
Date Revised 09.12.2020
published: Print
Citation Status MEDLINE
ISSN:0018-1994